Update: 21.05.2025
Last week: 19 week 2025 (05.05.2025 - 11.05.2025)
Last full month: April 2025
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 8 442 | 3.9% | 13.3% | 0.8 | 19 228 111 | 4.6% | 10.1% | 0.6 | -2.2% |
| MoM | 41 693 | -9.4% | 12.6% | -0.2 | 93 772 540 | -6.5% | 9.5% | -0.1 | -7.7% |
| YTD | 173 344 | 25.7% | 12.7% | 1.6 | 376 738 301 | 22.3% | 9.5% | 0 | 9.5% |
| MAT | 456 866 | 24.7% | 12.9% | 2.9 | 907 877 331 | 19.2% | 9.3% | 0.8 | -3.6% |
| BRAINMAX | |||||||||
| WoW | 2 344 | 0.2% | 100.0% | 0 | 8 069 167 | -2.3% | 100.0% | 0 | 0.2% |
| MoM | 11 719 | -12.4% | 100.0% | 0 | 41 169 227 | -8.3% | 100.0% | 0 | -12.4% |
| YTD | 47 192 | 132.0% | 100.0% | 0 | 163 505 817 | 126.9% | 100.0% | 0 | 132.0% |
| MAT | 109 518 | 104.2% | 100.0% | 0 | 378 152 459 | 101.3% | 100.0% | 0 | 104.2% |
| GOLDLINE PLUS | |||||||||
| WoW | 16 436 | 6.4% | 46.1% | 1.3 | 51 442 036 | 5.1% | 37.1% | 0.5 | 3.4% |
| MoM | 72 821 | -6.8% | 45.4% | -1.7 | 233 845 743 | -7.7% | 37.3% | -1.3 | -3.3% |
| YTD | 310 321 | -3.9% | 45.8% | 1.2 | 1 001 589 573 | -2.5% | 37.5% | 1 | -6.4% |
| MAT | 816 601 | -5.7% | 45.9% | 0.4 | 2 577 476 238 | -5.6% | 37.6% | -1 | -6.5% |
| MIGRENIUM | |||||||||
| WoW | 7 671 | 3.1% | 0.4% | 0 | 2 714 952 | 3.1% | 0.5% | 0 | -4.1% |
| MoM | 34 261 | -11.6% | 0.3% | 0 | 12 120 830 | -11.3% | 0.5% | 0 | -7.6% |
| YTD | 155 551 | -33.9% | 0.4% | -0.2 | 54 529 764 | -21.7% | 0.5% | -0.2 | 5.3% |
| MAT | 488 004 | -24.4% | 0.4% | -0.1 | 166 536 353 | 10.6% | 0.6% | 0 | 0.4% |
| MODELAX-N | |||||||||
| WoW | 24 936 | 3.9% | 19.1% | 1.4 | 13 854 933 | 6.1% | 14.1% | 1.1 | -3.5% |
| MoM | 114 169 | -9.4% | 18.7% | -0.5 | 61 079 234 | -7.6% | 13.7% | 0 | -7.2% |
| YTD | 556 148 | -6.6% | 20.2% | -3.5 | 291 335 462 | 17.5% | 14.5% | -0.5 | 9.4% |
| MAT | 1 424 094 | 3.8% | 20.4% | -0.3 | 702 659 727 | 38.4% | 14.0% | 1.8 | 5.4% |
| REDUXIN | |||||||||
| WoW | 10 775 | 1.1% | 30.2% | -0.7 | 58 576 896 | 1.5% | 42.3% | -0.9 | 3.4% |
| MoM | 50 473 | -3.6% | 31.5% | -0.1 | 272 682 487 | -4.4% | 43.5% | 0 | -3.3% |
| YTD | 214 874 | -10.3% | 31.7% | -1.4 | 1 168 671 058 | -10.0% | 43.7% | -2.4 | -6.4% |
| MAT | 570 820 | -7.5% | 32.1% | -0.3 | 3 032 876 806 | -2.2% | 44.2% | 0.4 | -6.5% |
| REDUXIN FORTE | |||||||||
| WoW | 3 853 | 9.0% | 10.8% | 0.6 | 18 254 346 | 12.7% | 13.2% | 1.1 | 3.4% |
| MoM | 15 756 | -0.7% | 9.8% | 0.3 | 71 449 643 | -1.6% | 11.4% | 0.3 | -3.3% |
| YTD | 67 305 | 6.9% | 9.9% | 1.2 | 305 117 715 | 11.2% | 11.4% | 1.7 | -6.4% |
| MAT | 171 715 | 1.7% | 9.7% | 0.8 | 752 349 950 | 6.9% | 11.0% | 1 | -6.5% |
| SALVISAR | |||||||||
| WoW | 11 312 | 3.3% | 1.6% | 0 | 5 862 061 | 4.2% | 1.6% | 0.1 | 0.7% |
| MoM | 54 824 | -3.3% | 1.7% | 0 | 27 866 396 | -1.2% | 1.7% | 0 | -2.2% |
| YTD | 251 402 | 25.2% | 1.8% | 0.4 | 123 388 571 | 57.1% | 1.8% | 0.5 | -4.5% |
| MAT | 622 397 | 25.5% | 1.6% | 0.4 | 285 793 498 | 61.7% | 1.5% | 0.5 | -6.9% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 173 344 | 25.7% | 12.7% | 1.6 | 376 738 301 | 22.3% | 9.5% | 0 | 9.5% |
| BRAINMAX | 47 192 | 132.0% | 100.0% | 0 | 163 505 817 | 126.9% | 100.0% | 0 | 132.0% |
| GOLDLINE PLUS | 310 321 | -3.9% | 45.8% | 1.2 | 1 001 589 573 | -2.5% | 37.5% | 1 | -6.4% |
| MIGRENIUM | 155 551 | -33.9% | 0.4% | -0.2 | 54 529 764 | -21.7% | 0.5% | -0.2 | 5.3% |
| MODELAX-N | 556 148 | -6.6% | 20.2% | -3.5 | 291 335 462 | 17.5% | 14.5% | -0.5 | 9.4% |
| REDUXIN CAPS | 214 874 | -10.3% | 31.7% | -1.4 | 1 168 671 058 | -10.0% | 43.7% | -2.4 | -6.4% |
| REDUXIN FORTE | 67 305 | 6.9% | 9.9% | 1.2 | 305 117 715 | 11.2% | 11.4% | 1.7 | -6.4% |
| SALVISAR | 251 402 | 25.2% | 1.8% | 0.4 | 123 388 571 | 57.1% | 1.8% | 0.5 | -4.5% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 456 866 | 24.7% | 12.9% | 2.9 | 907 877 331 | 19.2% | 9.3% | 0.8 | -3.6% |
| BRAINMAX | 109 518 | 104.2% | 100.0% | 0 | 378 152 459 | 101.3% | 100.0% | 0 | 104.2% |
| GOLDLINE PLUS | 816 601 | -5.7% | 45.9% | 0.4 | 2 577 476 238 | -5.6% | 37.6% | -1 | -6.5% |
| MIGRENIUM | 488 004 | -24.4% | 0.4% | -0.1 | 166 536 353 | 10.6% | 0.6% | 0 | 0.4% |
| MODELAX-N | 1 424 094 | 3.8% | 20.4% | -0.3 | 702 659 727 | 38.4% | 14.0% | 1.8 | 5.4% |
| REDUXIN CAPS | 570 820 | -7.5% | 32.1% | -0.3 | 3 032 876 806 | -2.2% | 44.2% | 0.4 | -6.5% |
| REDUXIN FORTE | 171 715 | 1.7% | 9.7% | 0.8 | 752 349 950 | 6.9% | 11.0% | 1 | -6.5% |
| SALVISAR | 622 397 | 25.5% | 1.6% | 0.4 | 285 793 498 | 61.7% | 1.5% | 0.5 | -6.9% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 8 442 | 3.9% | 13.3% | 0.8 | 19 228 111 | 4.6% | 10.1% | 0.6 | -2.2% |
| BRAINMAX | 2 344 | 0.2% | 100.0% | 0 | 8 069 167 | -2.3% | 100.0% | 0 | 0.2% |
| GOLDLINE PLUS | 16 436 | 6.4% | 46.1% | 1.3 | 51 442 036 | 5.1% | 37.1% | 0.5 | 3.4% |
| MIGRENIUM | 7 671 | 3.1% | 0.4% | 0 | 2 714 952 | 3.1% | 0.5% | 0 | -4.1% |
| MODELAX-N | 24 936 | 3.9% | 19.1% | 1.4 | 13 854 933 | 6.1% | 14.1% | 1.1 | -3.5% |
| REDUXIN CAPS | 10 775 | 1.1% | 30.2% | -0.7 | 58 576 896 | 1.5% | 42.3% | -0.9 | 3.4% |
| REDUXIN FORTE | 3 853 | 9.0% | 10.8% | 0.6 | 18 254 346 | 12.7% | 13.2% | 1.1 | 3.4% |
| SALVISAR | 11 312 | 3.3% | 1.6% | 0 | 5 862 061 | 4.2% | 1.6% | 0.1 | 0.7% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 41 693 | -9.4% | 12.6% | -0.2 | 93 772 540 | -6.5% | 9.5% | -0.1 | -7.7% |
| BRAINMAX | 11 719 | -12.4% | 100.0% | 0 | 41 169 227 | -8.3% | 100.0% | 0 | -12.4% |
| GOLDLINE PLUS | 72 821 | -6.8% | 45.4% | -1.7 | 233 845 743 | -7.7% | 37.3% | -1.3 | -3.3% |
| MIGRENIUM | 34 261 | -11.6% | 0.3% | 0 | 12 120 830 | -11.3% | 0.5% | 0 | -7.6% |
| MODELAX-N | 114 169 | -9.4% | 18.7% | -0.5 | 61 079 234 | -7.6% | 13.7% | 0 | -7.2% |
| REDUXIN CAPS | 50 473 | -3.6% | 31.5% | -0.1 | 272 682 487 | -4.4% | 43.5% | 0 | -3.3% |
| REDUXIN FORTE | 15 756 | -0.7% | 9.8% | 0.3 | 71 449 643 | -1.6% | 11.4% | 0.3 | -3.3% |
| SALVISAR | 54 824 | -3.3% | 1.7% | 0 | 27 866 396 | -1.2% | 1.7% | 0 | -2.2% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs